Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Mandated quality measures and economic implications of venous thromboembolism prevention and management.

Passman MA.

Am J Surg. 2010 Jan;199(1 Suppl):S21-31. doi: 10.1016/j.amjsurg.2009.10.005. Review.

PMID:
20103081
2.

Deep vein thrombosis prophylaxis in hospitalized medical patients: current recommendations, general rates of implementation, and initiatives for improvement.

Stevens SM, Douketis JD.

Clin Chest Med. 2010 Dec;31(4):675-89. doi: 10.1016/j.ccm.2010.07.005. Review.

PMID:
21047575
3.

Development of national performance measures on the prevention and treatment of venous thromboembolism.

Bratzler DW.

J Thromb Thrombolysis. 2010 Feb;29(2):148-54. doi: 10.1007/s11239-009-0407-2.

PMID:
19915995
4.
5.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
6.

Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.

Le Sage S, McGee M, Emed JD.

J Vasc Nurs. 2008 Dec;26(4):109-17. doi: 10.1016/j.jvn.2008.09.005.

PMID:
19022169
7.

Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors.

Muntz JE, Michota FA.

Am J Surg. 2010 Jan;199(1 Suppl):S11-20. doi: 10.1016/j.amjsurg.2009.10.007. Review.

PMID:
20103080
8.

Prophylaxis of venous thromboembolism in the US: improving hospital performance.

Cohn SL.

J Thromb Haemost. 2009 Sep;7(9):1437-45. doi: 10.1111/j.1538-7836.2009.03533.x. Epub 2009 Jun 27.

9.

Risk assessment as a guide for the prevention of the many faces of venous thromboembolism.

Caprini JA.

Am J Surg. 2010 Jan;199(1 Suppl):S3-10. doi: 10.1016/j.amjsurg.2009.10.006. Review.

PMID:
20103082
10.

Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.

Al Sayegh F, Almahmeed W, Al Humood S, Marashi M, Bahr A, Al Mahdi H, Bakir S, Al Farhan M.

Clin Appl Thromb Hemost. 2009 May-Jun;15(3):289-96. doi: 10.1177/1076029608315168. Epub 2008 Apr 8.

PMID:
18400764
11.
13.

Performance measures for improving the prevention of venous thromboembolism: achievement in clinical practice.

Wilson KC, Merli GJ.

J Thromb Thrombolysis. 2011 Oct;32(3):293-302. doi: 10.1007/s11239-011-0605-6.

PMID:
21667203
14.

An overview of venous thromboembolism: impact, risks, and issues in prophylaxis.

Jaffer AK.

Cleve Clin J Med. 2008 Apr;75 Suppl 3:S3-6. Review.

PMID:
18494222
15.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
16.

Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.

Sullivan SD, Kahn SR, Davidson BL, Borris L, Bossuyt P, Raskob G.

Pharmacoeconomics. 2003;21(7):477-96. Review.

PMID:
12696988
17.

VTE as a quality indicator.

Goldsmith M, Whitelaw G, Cannaday DA.

J Natl Compr Canc Netw. 2008 Sep;6(8):754-9.

PMID:
18926087
18.

Diagnosis and initial treatment of venous thromboembolism in patients with cancer.

Streiff MB.

J Clin Oncol. 2009 Oct 10;27(29):4889-94. doi: 10.1200/JCO.2009.23.5788. Epub 2009 Sep 8. Review.

PMID:
19738109
19.
20.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445

Supplemental Content

Support Center